Scribd Logo
Upload

Welcome to Scribd!

  • 211 views

    Dr. Regina Engelstaedter

    Uploaded by

    Popovici Liviu
    Dr. Regina Engelstaedter is a partner at the law firm Paul Hastings based in their Frankfurt, Germany office. She advises clients on domestic and international mergers and acquisitions and corporate matters. Some of her recent representations include advising Boon Rawd Brewery Company on a joint venture with a German juice company, advising a financial investor on acquiring assets from Daimler, and advising Fosun Pharma and BioNTech on forming a strategic alliance to develop a COVID-19 vaccine. She has been recognized in several publications for her work in M&A transactions.

    Copyright:

    © All Rights Reserved
    Download as PDF, TXT or read online from Scribd

    Dr. Regina Engelstaedter

    Uploaded by

    Popovici Liviu
    211 views5 pages
    Dr. Regina Engelstaedter is a partner at the law firm Paul Hastings based in their Frankfurt, Germany office. She advises clients on domestic and international mergers and acquisitions and corporate matters. Some of her recent representations include advising Boon Rawd Brewery Company on a joint venture with a German juice company, advising a financial investor on acquiring assets from Daimler, and advising Fosun Pharma and BioNTech on forming a strategic alliance to develop a COVID-19 vaccine. She has been recognized in several publications for her work in M&A transactions.

    Copyright

    © © All Rights Reserved

    Available Formats

    PDF, TXT or read online from Scribd

    Did you find this document useful?

    Is this content inappropriate?

    Dr. Regina Engelstaedter is a partner at the law firm Paul Hastings based in their Frankfurt, Germany office. She advises clients on domestic and international mergers and acquisitions and corporate matters. Some of her recent representations include advising Boon Rawd Brewery Company on a joint venture with a German juice company, advising a financial investor on acquiring assets from Daimler, and advising Fosun Pharma and BioNTech on forming a strategic alliance to develop a COVID-19 vaccine. She has been recognized in several publications for her work in M&A transactions.

    Copyright:

    © All Rights Reserved
    Download as PDF, TXT or read online from Scribd
    Download as pdf or txt
    211 views5 pages

    Dr. Regina Engelstaedter

    Uploaded by

    Popovici Liviu
    Dr. Regina Engelstaedter is a partner at the law firm Paul Hastings based in their Frankfurt, Germany office. She advises clients on domestic and international mergers and acquisitions and corporate matters. Some of her recent representations include advising Boon Rawd Brewery Company on a joint venture with a German juice company, advising a financial investor on acquiring assets from Daimler, and advising Fosun Pharma and BioNTech on forming a strategic alliance to develop a COVID-19 vaccine. She has been recognized in several publications for her work in M&A transactions.

    Copyright:

    © All Rights Reserved
    Download as PDF, TXT or read online from Scribd
    Download as pdf or txt
    You are on page 1of 5

    Atlanta, Beijing, Brussels, Chicago, Frankfurt, Hong Kong, Houston, London

    Los Angeles, Milan, New York, Orange County, Palo Alto, Paris
    San Diego, San Francisco, São Paulo, Seoul, Shanghai, Tokyo, Washington DC

    Dr. Regina Engelstaedter


    Partner, Corporate Department
    reginaengelstaedter@paulhastings.com

    Dr. Regina Engelstädter is a partner in the Corporate practice of Paul Hastings Frankfurt
    and is based in the firm’s Frankfurt office. She advises clients on domestic and T: 49 69 907485-110
    international M&A transactions and corporate matters including corporate F: 49 69 907485-310
    restructurings and joint ventures. Dr. Engelstädter advises strategic and financial
    investors in auction processes and buy-outs. Practice Areas
    Corporate
    Recent Representations Life Sciences and Healthcare
    Europe
    • Advised Boon Rawd Brewery Company Limited in connection with a Joint
    Mergers and Acquisitions
    Venture agreement with Valensina Holding GmbH. Valensina is a leading Fintech and Payments
    German fruit juice manufacturer and the second largest branded fruit juice Private Equity
    company in Germany. Payment Systems
    • Advised a financial investor in connection with the acquisition of sales offices
    from Daimler AG. Admissions
    • Advised Dexcom, Inc. (NASDAQ: DXCM), a leading manufacturer of blood
    Germany
    pressure monitors (Dexcom G5 Mobile Continous Glucose Monitoring System)
    in connection with the acquisition of Nintamed Group in Germany, Austria and
    Switzerland. Education
    • Advised Fujian Grand Chip Investment Fund LP (FGC), a Chinese investor, in Johann Wolfgang Goethe-
    connection with the public takeover offer regarding all shares of Aixtron SE. Universitat Frankfurt am Main,
    • Advised Hansol on its acquisition of all share capital of R+S Group GmbH, a 1 St Exam 1994
    Johann Wolfgang Goethe-
    thermal paper converting company in Germany, and on the acquisition of
    Universitat Frankfurt am Main,
    Schades Group from Capidea Kapital, a Danish private equity fund. 2 St Exam 1998
    • Advised financial investor Keensight Capital in connection with the acquisition Johann Wolfgang Goethe-
    of aap Biomaterials GmbH, a subsidiary of aap Implanate AG. Universitat Frankfurt am Main,
    • Advised financial investor Madison Industries, on the acquisition of the Porous Dr. iur. 1997

    Technologies business of UK-based industrial group Essentra plc for £220


    million.
    • Advised the biopharmaceutical company MSD (tradename of Merck & Co.,
    Inc., Kenilworth, N.J., USA (NYSE: MRK)) on its acquisition of Munich-
    headquartered therapeutics company Rigontec.
    Atlanta, Beijing, Brussels, Chicago, Frankfurt, Hong Kong, Houston, London
    Los Angeles, Milan, New York, Orange County, Palo Alto, Paris
    San Diego, San Francisco, São Paulo, Seoul, Shanghai, Tokyo, Washington DC

    Dr. Regina Engelstaedter (Continued)


    • Advised Nexter Systems SA on the defense Joint Venture with Nexter Systems
    SA and Krauss-Maffei Wegmann GmbH & Co. KG.
    • Advised Publicis Group SA (Starcom Mediavest Group GmbH) in connection
    with the Acquisition of AKM3 and AKOM360 GmbH, a leading German digital
    agency located in Munich and Düsseldorf.
    • Advised Schott AG, an international technology group and one of the world’s
    largest producers of industrial glass and glass products, in connection with the
    Sale of Schott Medica GmbH and related business units.
    • Advised Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (“Fosun Pharma”;
    Stock Code: 600196.SH, 02196.HK), one of the leading Chinese healthcare
    groups, in forming a strategic alliance with Biopharmaceutical New
    Technologies of Germany (“BioNTech”; Nasdaq: BNTX) to develop and
    commercialize a vaccine that prevents COVID-19 infections using BioNTech’s
    mRNA vaccine candidate BNT162.
    • Advised SMA Solar Technology AG in the acquisition of Tigo Energy Inc.

    Accolades and Recognitions


    • Dr. Engelstädter is listed by "The Best Lawyers in Germany" Handelsblatt for
    M&A 2019
    • She is "frequently recommended" for Private Equity and M&A(JUVE
    2018/2019)
    • Dr. Engelstädter was recognized by Who’s Who Legal: Germany 2018 as "a
    superb advocate who enjoys a fantastic reputation in the market for providing
    expert advice on domestic and international M&A transactions"
    • JUVE recommends Dr. Engelstädter as "superior and strong negotiator"
    (2017/2018)
    • "Finance Top Deal of the Year" awarded by the National Association of
    Mergers & Acquisition in cooperation with the magazine Finance for excellence
    in strategy and implementation of an M&A transaction (advised Schott AG on
    the sale of Schott Medica GmbH and related business units)

    Speaking Engagements and Publications


    • Dr. Engelstädter is a speaker at seminars on corporate / M&A law issues,
    including "Cross Border M&A" and "Shareholder Activism, Public Intervention
    und Legal Tech".

    Education
    • Johann Wolfgang von Goethe University, Dr. iur., 1997
    • Johann Wolfgang von Goethe University, 2 St Exam, 1998
    • Johann Wolfgang von Goethe University, 1 St Exam, 1994
    Atlanta, Beijing, Brussels, Chicago, Frankfurt, Hong Kong, Houston, London
    Los Angeles, Milan, New York, Orange County, Palo Alto, Paris
    San Diego, San Francisco, São Paulo, Seoul, Shanghai, Tokyo, Washington DC

    Dr. Regina Engelstaedter (Continued)


    • Appointment as notary public by the President of the Higher Regional Court of
    Frankfurt am Main

    News

    March 18, 2020


    Fosun Pharma and BioNTech Form COVID-19 Vaccine Strategic Alliance in
    China

    November 06, 2018


    Hansol Paper Sells European Companies to Iconex

    June 14, 2018


    CDH Investments to Acquire Sirtex for US$1.4 Billion

    September 07, 2017


    MSD to Acquire Therapeutics Pioneer Rigontec

    August 25, 2016


    Filtration Group Acquires Essentra’s Porous Technologies Business

    May 25, 2016


    Fujian Grand Chip Investment Fund Acquires Germany’s Aixtron for €670 Million

    May 12, 2016


    Keensight Capital Undertakes Complex German Acquisition and Subsequent
    Italian Merger

    May 02, 2016


    DexCom Acquires its Distributor in Germany, Switzerland and Austria

    November 16, 2015


    Singha Europe Company Invests in Germany's Valensina Holding

    September 07, 2015


    Hansol Paper Acquires German Thermal Paper Converting Company

    July 29, 2015


    France’s Nexter Systems Merges with Germany’s KMW

    June 24, 2015


    Atlanta, Beijing, Brussels, Chicago, Frankfurt, Hong Kong, Houston, London
    Los Angeles, Milan, New York, Orange County, Palo Alto, Paris
    San Diego, San Francisco, São Paulo, Seoul, Shanghai, Tokyo, Washington DC

    Dr. Regina Engelstaedter (Continued)


    Publicis Group/Starcom Mediavest Group Acquires Akom 360

    February 12, 2015


    Paul Hastings Advises U.S. PE Portfolio Companies on Acquisitions in UK,
    Germany and Canada

    September 10, 2014


    Paul Hastings Advises Publicis Group/ZenithOptimedia on Acquisition of
    Germany’s AKM3

    October 02, 2013


    Paul Hastings Advises Hansol Paper on European Acquisition

    August 31, 2012


    Paul Hastings Represents Weichai Power in Investment in KION Group

    April 12, 2012


    Christopher Wolff Appointed Chair of Paul Hastings Frankfurt Office

    Insights

    June 24, 2020


    Foreign Investment Control and COVID-19 in Germany

    March 24, 2020


    PH COVID-19 Client Alert Series: Force Majeure Provisions // German Legislator
    Aims to Mitigate Consequences of the Corona-Pandemic by Changing Civil,
    Corporate, and Insolvency Law

    November 18, 2019


    Cross-border M&A: A Different Mindset

    September 12, 2019


    New German Act to Combat Corporate Crime

    September 12, 2019


    EU Adopted Regulation on Screening of Foreign Investments

    December 19, 2018


    EU Screening of Foreign Investments
    Atlanta, Beijing, Brussels, Chicago, Frankfurt, Hong Kong, Houston, London
    Los Angeles, Milan, New York, Orange County, Palo Alto, Paris
    San Diego, San Francisco, São Paulo, Seoul, Shanghai, Tokyo, Washington DC

    Dr. Regina Engelstaedter (Continued)


    February 09, 2015
    Global M&A: Momentum for Growth Report

    July 25, 2014


    Global M&A 2014 Mid-Year Report

    May 16, 2014


    Where are the greatest investment opportunities for inbound European M&A?

    January 13, 2014


    The German Foreign Trade Law and Its Effects on International M&A
    Transactions

    November 20, 2013


    New EU Data Protection Laws - European Parliament Proposes Restrictive Data
    Protection Laws in Europe

    July 16, 2013


    Joint Venture Agreements in Light of Emerging Accounting Amendments

    You might also like